Pegcetacoplan for Geographic Atrophy Over 30 Months: Data From OAKS, DERBY, and the GALE Long-Term Extension Study

Pegcetacoplan reduced GA growth rate up to 45% with increasing efficacy over 30 months and demonstrated a favorable safety profile. <b>[<i>Ophthalmic Surg Lasers Imaging Retina</i> 2025;56:398-406.]</b>.